Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion

Table 1

Screening demographic and biochemical characteristics of study population.

	Participants without primary HPT	Participants with primary HPT
Age, years	39.6 (12.7)	51.4 (15.6)
Female, number (%)	6 (40)	5 (42)
White, number (%)	8 (53)	9 (75)
SBP, mmHg	120.0 (18.0)	121.4 (12.6)
DBP, mmHg	78.1 (12.0)	76.7 (5.2)
Number with hypertension	1	2
Number on antihypertensive therapy	0	3
PTH, pg/mL	21.8 (5.7)	94.8 (29.0)
25(OH)D, ng/mL	23.0 (8.6)	28.8 (10.7)
Serum calcium	9.6 (0.3)	11.0 (0.4)
Serum creatinine, mg/dL	0.84 (0.10)	0.83 (0.13)
Serum potassium, mmol/L	4.5 (0.5)	4.5 (0.3)

Values are mean (SD) unless otherwise noted. HPT: hyperparathyroidism; SBP: systolic blood pressure; DBP: diastolic blood pressure; PTH: parathyroid hormone; 25(OH)D: 25-hydroxyvitamin D.